Zaandam, the Netherlands, August 8, 2017 - Ahold Delhaize has repurchased 1,564,286 of Ahold Delhaize common shares in the period from July 31, 2017 up to and including August 4, 2017. The shares were repurchased at an average price of €17.45 per share for a total consideration of €27.3 million. These repurchases were made as part of the €1 billion share buyback program announced on December 7, 2016.
The total number of shares repurchased under this program to date is 35,529,446 common shares for a total consideration of €675 million.
Download the share buyback transactions excel sheet for detailed individual transaction information from www.aholddelhaize.com/en/investors/share-information/share-buy-back-programs/


FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Volaris and Viva Agree to Merge, Creating Mexico’s Largest Low-Cost Airline Group
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand
ANZ New CEO Forgoes Bonus After Shareholders Reject Executive Pay Report
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
Trump Administration Reviews Nvidia H200 Chip Sales to China, Marking Major Shift in U.S. AI Export Policy
Roche CEO Warns US Drug Price Deals Could Raise Costs of New Medicines in Switzerland
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 



